Preterm birth and intra-partum related complications account for a substantial amount of
mortality and morbidity in the neonatal period despite significant advancements in neonatal …

Introduction We have previously described preclinical literature which supports umbilical
cord blood-derived cell (UCBC) therapy as an efficacious treatment for perinatal brain injury …

Neonatologists resuscitate asphyxiated neonates by every available means, including
positive ventilation, oxygen therapy, and drugs. Asphyxiated neonates sometimes present …

Hypoxic–ischemic encephalopathy (HIE) is a leading cause of long‐term neurological
disability in neonates and adults. Despite emerging advances in supportive care, like the …

Objective: Therapeutic hypothermia (TH) is the current standard of care for neonatal hypoxic-
ischemic encephalopathy (HIE), yet morbidity and mortality remain significant. Adjuvant …

Perinatal brain injury is a major contributor to long-term adverse neurodevelopment. There
is mounting preclinical evidence for use of umbilical cord blood (UCB)-derived cell therapy …

Human umbilical cord blood (CB) and umbilical cord tissue (UC) are attractive sources of
somatic stem cells for gene and cell therapies. CB and UC can be obtained noninvasively …

Neonatal hypoxic-ischemic encephalopathy (HIE) is a common disease among newborns,
which is a leading cause of neonatal death and permanent neurological sequelae …

Background: Despite the progress in perinatal-neonatal medicine, complications of
extremely preterm infants continue to constitute the major adverse outcomes in neonatal …

The aim of this study was to identify related scientific outputs and emerging topics of stem
cells in neonatal hypoxic-ischemic encephalopathy (NHIE) and cerebral palsy (CP) through …